Efficacy and Safety of Dual Biologic Therapy in Patients With Inflammatory Bowel Disease: A Review of the Literature

Abstract: Using 2 or more treatment modalities to achieve a synergistic effect in patients with refractory inflammatory bowel disease (IBD) has been an area of focus […]

Diagnosis and Management of Immune Checkpoint Inhibitor Colitis

Abstract: Increased use of immune checkpoint inhibitors (ICIs) has created a rise in immune-related adverse events (irAEs), which may affect any system in the body. Gastrointestinal […]

Restarting Biologic Agents After a Drug Holiday

G&H What are the most common reasons that patients with inflammatory bowel disease have a drug holiday from biologic therapy? DR The most common reasons […]